{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:49:45Z","timestamp":1790909385089,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI084024"],"award-info":[{"award-number":["AI084024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.anaerobe.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T18:57:04Z","timestamp":1549825024000},"page":"61-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents"],"prefix":"10.1016","volume":"56","author":[{"given":"Melinda A.B.","family":"Petrina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold C.","family":"Wiesenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anaerobe.2019.02.005_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm6603a3","article-title":"Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age-United States, 2013-2014","volume":"66","author":"Kreisel","year":"2017","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"issue":"5","key":"10.1016\/j.anaerobe.2019.02.005_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial","volume":"186","author":"Ness","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"No.3","key":"10.1016\/j.anaerobe.2019.02.005_bib3","first-page":"69","article-title":"Sexually transmitted diseases treatment guidelines","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"issue":"0","key":"10.1016\/j.anaerobe.2019.02.005_bib4","first-page":"1","article-title":"European guideline for the management of pelvic inflammatory disease","volume":"0","author":"Ross","year":"2017","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.anaerobe.2019.02.005_bib5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajem.2011.07.014","article-title":"Laboratory-confirmed gonorrhea and\/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis","volume":"30","author":"Burnett","year":"2012","journal-title":"Am. J. Emerg. Med."},{"issue":"7","key":"10.1016\/j.anaerobe.2019.02.005_bib6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/423963","article-title":"Bacterial vaginosis and anaerobic bacteria are associated with endometritis","volume":"39","author":"Haggerty","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"476e1","DOI":"10.1016\/j.ajog.2012.02.036","article-title":"Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient servic","volume":"206","author":"Bjartling","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/aje\/kwi243","article-title":"A\u00a0cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease","volume":"162","author":"Ness","year":"2005","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","article-title":"Identification of novel microbes associated with pelvic inflammatory disease and infertility","volume":"92","author":"Haggerty","year":"2016","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib10","first-page":"85","volume":"vol. 57","author":"Heinonen","year":"1994"},{"issue":"4","key":"10.1016\/j.anaerobe.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiv438","article-title":"Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection","volume":"213","author":"Russell","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"issue":"S8","key":"10.1016\/j.anaerobe.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for disease control and prevention sexually transmitted diseases treatment guidelines","volume":"64","author":"Workowski","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.anaerobe.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/infdis\/jiw485","article-title":"Identification of Chlamydia trachomatis antigens recognized by T Cells from highly exposed women who limit or resist genital tract infection","volume":"214","author":"Russell","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib14","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.anaerobe.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","article-title":"Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin","volume":"47","author":"Petrina","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2019.02.005_bib16","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. CLSI Document M100-S12","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2002"},{"issue":"12","key":"10.1016\/j.anaerobe.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","article-title":"Antibiotic susceptibility testing of Mycoplasma genitalium by Taqman 5\u2019 nuclease real-time PCR","volume":"49","author":"Hamasuna","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/0002-9343(89)90045-4","article-title":"Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin","volume":"87","author":"Crombleholme","year":"1989","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.02.005_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/ijsa.2009.009374","article-title":"A\u00a0comparison of treatment of outcome for moxifloxacin versus ofloxacin\/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease","volume":"21","author":"Boothby","year":"2010","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.anaerobe.2019.02.005_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","article-title":"Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial","volume":"82","author":"Ross","year":"2006","journal-title":"Sex. Transm. Infect."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/sti.2007.024752","article-title":"A\u00a0serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy","volume":"83","author":"Jurstrand","year":"2007","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/sti.2005.015701","article-title":"Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis","volume":"81","author":"Cohen","year":"2005","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/sti.2008.030486","article-title":"Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease","volume":"84","author":"Haggerty","year":"2008","journal-title":"Sex. Transm. Infect."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.02.005_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/sextrans-2017-053376","article-title":"Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response against Chlamydia (TRAC) study","volume":"94","author":"Taylor","year":"2018","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.anaerobe.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/infdis\/jiv079","article-title":"Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis","volume":"212","author":"Mayer","year":"2015","journal-title":"J.\u00a0Infect. Dis."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419300289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419300289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:36:25Z","timestamp":1761035785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996419300289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"alternative-id":["S1075996419300289"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.02.005","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}